{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:57:52Z","timestamp":1777705072798,"version":"3.51.4"},"reference-count":79,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HEALTHY AGING 2020","award":["CENTRO-01-0145-FEDER-000012"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-000012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The availability of cytogenetics and cytogenomics technologies improved the detection and identification of tumor molecular signatures as well as the understanding of cancer initiation and progression. The use of large-scale and high-throughput cytogenomics technologies has led to a fast identification of several cancer candidate biomarkers associated with diagnosis, prognosis, and therapeutics. The advent of array comparative genomic hybridization and next-generation sequencing technologies has significantly improved the knowledge about cancer biology, underlining driver genes to guide targeted therapy development, drug-resistance prediction, and pharmacogenetics. However, few of these candidate biomarkers have made the transition to the clinic with a clear benefit for the patients. Technological progress helped to demonstrate that cellular heterogeneity plays a significant role in tumor progression and resistance\/sensitivity to cancer therapies, representing the major challenge of precision cancer therapy. A paradigm shift has been introduced in cancer genomics with the recent advent of single-cell sequencing, since it presents a lot of applications with a clear benefit to oncological patients, namely, detection of intra-tumoral heterogeneity, mapping clonal evolution, monitoring the development of therapy resistance, and detection of rare tumor cell populations. It seems now evident that no single biomarker could provide the whole information necessary to early detect and predict the behavior and prognosis of tumors. The promise of precision medicine is based on the molecular profiling of tumors being vital the continuous progress of high-throughput technologies and the multidisciplinary efforts to catalogue chromosomal rearrangements and genomic alterations of human cancers and to do a good interpretation of the relation genotype\u2014phenotype.<\/jats:p>","DOI":"10.3390\/ijms20194711","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:02:00Z","timestamp":1569236520000},"page":"4711","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cytogenetics and Cytogenomics Evaluation in Cancer"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-8705","authenticated-orcid":false,"given":"Ilda Patr\u00edcia","family":"Ribeiro","sequence":"first","affiliation":[{"name":"Cytogenetics and Genomics Laboratory, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal"},{"name":"iCBR-CIMAGO, Center of Investigation on Environment, Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal"}]},{"given":"Joana Barbosa","family":"Melo","sequence":"additional","affiliation":[{"name":"Cytogenetics and Genomics Laboratory, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal"},{"name":"iCBR-CIMAGO, Center of Investigation on Environment, Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal"},{"name":"CNC, IBILI, Group of Aging and Brain Diseases: Advanced Diagnosis and Biomarkers, 3004-531 Coimbra, Portugal"}]},{"given":"Isabel Marques","family":"Carreira","sequence":"additional","affiliation":[{"name":"Cytogenetics and Genomics Laboratory, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal"},{"name":"iCBR-CIMAGO, Center of Investigation on Environment, Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal"},{"name":"CNC, IBILI, Group of Aging and Brain Diseases: Advanced Diagnosis and Biomarkers, 3004-531 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ng1569","article-title":"Array comparative genomic hybridization and its applications in cancer","volume":"37","author":"Pinkel","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/blood-2009-03-212969","article-title":"The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data","volume":"114","author":"Oehler","year":"2009","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.molonc.2010.06.003","article-title":"Cytogenomics of cancers: From chromosome to sequence","volume":"4","author":"Bernheim","year":"2010","journal-title":"Mol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.cell.2009.09.002","article-title":"Attacking cancer at its root","volume":"138","author":"Thompson","year":"2009","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.ajpath.2016.02.023","article-title":"Genomic and Epigenomic Alterations in Cancer","volume":"186","author":"Chakravarthi","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: Past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.2015.10080","article-title":"Integrative clinical sequencing in the management of refractory or relapsed cancer in youth","volume":"314","author":"Mody","year":"2015","journal-title":"Jama"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Heppt, M.V., Siepmann, T., Engel, J., Schubert-Fritschle, G., Eckel, R., Mirlach, L., Kirchner, T., Jung, A., Gesierich, A., and Ruzicka, T. (2017). Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3529-5"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13039-019-0447-z","article-title":"Head and neck cancer: Searching for genomic and epigenetic biomarkers in body fluids\u2014The state of art","volume":"12","author":"Ribeiro","year":"2019","journal-title":"Mol. Cytogenet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6703-2_1","article-title":"Cancer cytogenetics: An introduction","volume":"Volume 1541","author":"Wan","year":"2017","journal-title":"Cancer Cytogenetics"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gollin, S.M. (2005). Acquired chromosome abnormalities: The cytogenetics of cancer. Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics, John Wiley & Sons, Ltd.","DOI":"10.1002\/047001153X.g102204"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cge.12229","article-title":"Molecular cytogenetics: Recent developments and applications in cancer","volume":"84","author":"Das","year":"2013","journal-title":"Clin. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fcell.2016.00089","article-title":"Fluorescence in situ hybridization: Cell-based genetic diagnostic and research applications","volume":"4","author":"Cui","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1053\/beha.2001.0159","article-title":"Molecular cytogenetics","volume":"14","author":"Kearney","year":"2001","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/14737159.2.2.109","article-title":"FISH in cancer diagnosis and prognostication: From cause to course of disease","volume":"2","author":"Weier","year":"2002","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cncy.21327","article-title":"Evaluation of urovysion and cytology for bladder cancer detection: A study of 1835 paired urine samples with clinical and histologic correlation","volume":"121","author":"Dimashkieh","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s001090050169","article-title":"Tumor cytogenetics revisited: Comparative genomic hybridization and spectral karyotyping","volume":"75","author":"Ried","year":"1997","journal-title":"J. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10577-005-2168-x","article-title":"Array CGH technologies and their applications to cancer genomes","volume":"13","author":"Davies","year":"2005","journal-title":"Chromosome Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I","article-title":"Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances","volume":"20","author":"Lampel","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/12640","article-title":"Genome-wide analysis of DNA copy-number changes using cDNA microarrays","volume":"23","author":"Pollack","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.ejhg.5201531","article-title":"Recent advances in array comparative genomic hybridization technologies and their applications in human genetics","volume":"14","author":"Lockwood","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_22","first-page":"e108","article-title":"A broader view of cancer cytogenetics: From nuclear aberrations to cytogenomic abnormalities","volume":"10","author":"Li","year":"2017","journal-title":"J. Mol. Genet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrg2626","article-title":"Sequencing technologies\u2014The next generation","volume":"11","author":"Metzker","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PDM.0b013e3182595516","article-title":"Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics","volume":"21","author":"Savola","year":"2012","journal-title":"Diagn. Mol. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13402-013-0161-5","article-title":"Genetic gains and losses in oral squamous cell carcinoma: Impact on clinical management","volume":"37","author":"Ribeiro","year":"2014","journal-title":"Cell. Oncol."},{"key":"ref_26","first-page":"4687","article-title":"Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine","volume":"35","author":"Ribeiro","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2012.11.025","article-title":"Next-generation sequencing in the clinic: Promises and challenges","volume":"340","author":"Xuan","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kamps, R., Brandao, R.D., Bosch, B.J., Paulussen, A.D., Xanthoulea, S., Blok, M.J., and Romano, A. (2017). Next-generation sequencing in oncology: Genetic diagnosis, risk prediction and cancer classification. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020308"},{"key":"ref_29","first-page":"347","article-title":"Integrated analysis of tumor samples sheds light on tumor heterogeneity","volume":"85","author":"Parisi","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1101\/gr.191098.115","article-title":"The first five years of single-cell cancer genomics and beyond","volume":"25","author":"Navin","year":"2015","journal-title":"Genome Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biotechadv.2017.04.001","article-title":"Application of single-cell technology in cancer research","volume":"35","author":"Liang","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s13059-014-0452-9","article-title":"Cancer genomics: One cell at a time","volume":"15","author":"Navin","year":"2014","journal-title":"Genome Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.5808\/GI.2018.16.4.e17","article-title":"Single-cell ssequencing in cancer: Recent applications to immunogenomics and multi-omics tools","volume":"16","author":"Sierant","year":"2018","journal-title":"Genom. Inform."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000454655","article-title":"The genomic era of clinical oncology: Integrated genomic analysis for precision cancer care","volume":"150","author":"Surrey","year":"2016","journal-title":"Cytogenet. Genome Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ng1215","article-title":"Chromosome aberrations in solid tumors","volume":"34","author":"Albertson","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(96)00252-X","article-title":"Clinical significance of cytogenetic findings in solid tumors","volume":"95","author":"Mitelman","year":"1997","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-319-20291-4_6","article-title":"Patterns of chromosomal aberrations in solid tumors","volume":"200","author":"Grade","year":"2015","journal-title":"Recent Results Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6","article-title":"On the nature of susceptibility to cancer. The presidential address","volume":"46","author":"Miller","year":"1980","journal-title":"Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ejca.2003.11.039","article-title":"Viruses and tumours-an update","volume":"40","author":"Talbot","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Min, J.W., Kim, W.J., Han, J.A., Jung, Y.J., Kim, K.T., Park, W.Y., Lee, H.O., and Choi, S.S. (2015). Identification of distinct tumor subpopulations in lung adenocarcinoma via single-cell RNA-seq. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135817"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Shaw","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.30006","article-title":"Single-cell profiling approaches to probing tumor heterogeneity","volume":"139","author":"Khoo","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2159-8290.CD-15-0439","article-title":"Evolutionary determinants of cancer","volume":"5","author":"Greaves","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Raynaud, F., Mina, M., Tavernari, D., and Ciriello, G. (2018). Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007669"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrd3651","article-title":"Cancer biomarkers: Selecting the right drug for the right patient","volume":"11","author":"Kelloff","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molonc.2010.04.010","article-title":"Tracing the tumor lineage","volume":"4","author":"Navin","year":"2010","journal-title":"Mol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Sottoriva","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.28750","article-title":"Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics","volume":"135","author":"Tan","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1172\/JCI60534","article-title":"Heterogeneity in breast cancer","volume":"121","author":"Polyak","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2014.06.053","article-title":"Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer","volume":"8","author":"Brocks","year":"2014","journal-title":"Cell Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.2012.581","article-title":"Cancer heterogeneity: Implications for targeted therapeutics","volume":"108","author":"Fisher","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14796694.1.1.37","article-title":"Cancer biomarkers: Knowing the present and predicting the future","volume":"1","author":"Chatterjee","year":"2005","journal-title":"Future Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13039-016-0293-1","article-title":"Early detection and personalized treatment in oral cancer: The impact of omics approaches","volume":"9","author":"Ribeiro","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"ref_58","first-page":"256","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Trans. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/erm.12.132","article-title":"Integrated clinical genomics: New horizon for diagnostic and biomarker discoveries in cancer","volume":"13","author":"Roukos","year":"2013","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13402-016-0293-5","article-title":"WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers\u2014A short report","volume":"39","author":"Ribeiro","year":"2016","journal-title":"Cell. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/ddh155","article-title":"Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors","volume":"13","author":"Paris","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.1694","article-title":"Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays","volume":"205","author":"Callagy","year":"2005","journal-title":"J. Pathol."},{"key":"ref_63","first-page":"307","article-title":"Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival","volume":"26","author":"Weiss","year":"2004","journal-title":"Cell. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome","volume":"105","author":"Climent","year":"2005","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: A randomised, double-blind, placebo-controlled trial","volume":"373","author":"Dematteo","year":"2009","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"Pao","year":"2011","journal-title":"Lancet. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semcancer.2018.01.012","article-title":"New biomarkers for diagnosis and prognosis of localized prostate cancer","volume":"52","author":"Chistiakov","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/fon-2018-0221","article-title":"Mammaprint: A comprehensive review","volume":"15","author":"Brandao","year":"2019","journal-title":"Future Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1101\/gr.191114.115","article-title":"The path to routine use of genomic biomarkers in the cancer clinic","volume":"25","author":"Boutros","year":"2015","journal-title":"Genome Res."},{"key":"ref_76","first-page":"235","article-title":"\u2033Liquid biopsy\u2033-ctDNA detection with great potential and challenges","volume":"3","author":"Ma","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","article-title":"Liquid biopsies in cancer diagnosis, monitoring, and prognosis","volume":"40","author":"Bebawy","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/atm.2017.01.32","article-title":"The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?","volume":"5","author":"Kwapisz","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2018.01.011","article-title":"Clinical applications of the CellSearch platform in cancer patients","volume":"125","author":"Riethdorf","year":"2018","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/19\/4711\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:23:13Z","timestamp":1760188993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/19\/4711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":79,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["ijms20194711"],"URL":"https:\/\/doi.org\/10.3390\/ijms20194711","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]}}}